We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Mindfulness-Based Cognitive Therapy (MBCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00943033
Recruitment Status : Completed
First Posted : July 21, 2009
Last Update Posted : September 21, 2012
Information provided by (Responsible Party):

Study Description
Brief Summary:
Research aimed at assessing changes in depressogenic thinking and the ability to disengage from depressogenic thinking following Mindfulness-Based Cognitive Therapy

Condition or disease Intervention/treatment
Major Depressive Disorder Behavioral: Mindfulness-Based Cognitive Therapy

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Toward Identifying the Mechanisms of Action in Mindfulness-Based Cognitive Therapy
Study Start Date : August 2009
Primary Completion Date : July 2010
Study Completion Date : July 2010
Arms and Interventions

Arm Intervention/treatment
Experimental: Mindfulness-Based Cognitive Therapy plus treatment as usual Behavioral: Mindfulness-Based Cognitive Therapy
Mindfulness-Based Cognitive Therapy for the prevention of depressive relapse/recurrence
No Intervention: MBCT Waitlist plus Treatment as Usual

Outcome Measures

Primary Outcome Measures :
  1. Sustained Attention to Response Task [ Time Frame: zero to four weeks pre-treatment and zero to three weeks post-treatment ]

Secondary Outcome Measures :
  1. Five Facet Mindfulness Questionnaire [ Time Frame: zero to four weeks pre-treatment and zero to three weeks post-treatment ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • History of two or more Major Depressive Episodes or history of a Major Depressive Episode lasting at least one year
  • Can speak, read, and understand English

Exclusion Criteria:

  • Meet Criteria for Current Major Depressive Episode or are in partial remission
  • BDI-II score above 19
  • Abuse alcohol or drugs
  • Current Dysthymic Disorder
  • History of: psychosis when not depressed or intoxicated, Mania, Hypomania, Obsessive Compulsive Disorder, Posttraumatic Stress Disorder, Anorexia Nervosa, Bulimia Nervosa
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00943033

Sponsors and Collaborators
Binghamton University
Principal Investigator: Sean M. Barnes, MS Binghamton University SUNY
More Information

Responsible Party: Sean Barnes, PhD, Binghamton University
ClinicalTrials.gov Identifier: NCT00943033     History of Changes
Other Study ID Numbers: MLI-FJVRF-08-SMB
First Posted: July 21, 2009    Key Record Dates
Last Update Posted: September 21, 2012
Last Verified: September 2012

Keywords provided by Sean Barnes, Binghamton University:
Mindfulness-Based Cognitive Therapy
Relapse Prevention
Recurrent Depression
Major Depressive Disorder

Additional relevant MeSH terms:
Depressive Disorder
Depressive Disorder, Major
Mood Disorders
Mental Disorders
Behavioral Symptoms